Is FTRE or SHC more profitable?

Sotera Health has a net margin of 9.91% compared to Fortrea's net margin of -16.50%. Sotera Health's return on equity of 39.73% beat Fortrea's return on equity. Company Net Margins Return on Equity Return on Assets Fortrea -16.50% 9.51% 1.96% Sotera Health 9.91% 39.73% 7.05%

Does the media prefer FTRE or SHC?

In the previous week, Fortrea had 1 more articles in the media than Sotera Health. MarketBeat recorded 3 mentions for Fortrea and 2 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.15 beat Fortrea's score of 0.93 indicating that Sotera Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fortrea 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sotera Health 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer FTRE or CAI?

In the previous week, Caris Life Sciences had 1 more articles in the media than Fortrea. MarketBeat recorded 4 mentions for Caris Life Sciences and 3 mentions for Fortrea. Fortrea's average media sentiment score of 0.93 beat Caris Life Sciences' score of 0.33 indicating that Fortrea is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fortrea 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Caris Life Sciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings and valuation, RDNT or FTRE?

RadNet has higher earnings, but lower revenue than Fortrea. RadNet is trading at a lower price-to-earnings ratio than Fortrea, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio RadNet $2.14B 1.94 -$18.65M -$0.18 N/A Fortrea $2.72B 0.54 -$986.20M -$4.91 N/A

Is RDNT or FTRE more profitable?

RadNet has a net margin of -0.66% compared to Fortrea's net margin of -16.50%. Fortrea's return on equity of 9.51% beat RadNet's return on equity. Company Net Margins Return on Equity Return on Assets RadNet -0.66% 2.77% 0.97% Fortrea -16.50% 9.51% 1.96%

Does the media refer more to RDNT or FTRE?

In the previous week, RadNet had 2 more articles in the media than Fortrea. MarketBeat recorded 5 mentions for RadNet and 3 mentions for Fortrea. Fortrea's average media sentiment score of 0.93 beat RadNet's score of 0.30 indicating that Fortrea is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Fortrea 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to FTRE or BLLN?

In the previous week, Billiontoone had 2 more articles in the media than Fortrea. MarketBeat recorded 5 mentions for Billiontoone and 3 mentions for Fortrea. Billiontoone's average media sentiment score of 1.09 beat Fortrea's score of 0.93 indicating that Billiontoone is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fortrea 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Billiontoone 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, VCYT or FTRE?

Veracyte has higher earnings, but lower revenue than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Veracyte $517.15M 7.47 $66.35M $1.09 44.44 Fortrea $2.72B 0.54 -$986.20M -$4.91 N/A

Is VCYT or FTRE more profitable?

Veracyte has a net margin of 16.25% compared to Fortrea's net margin of -16.50%. Fortrea's return on equity of 9.51% beat Veracyte's return on equity. Company Net Margins Return on Equity Return on Assets Veracyte 16.25% 9.07% 8.38% Fortrea -16.50% 9.51% 1.96%

Does the media favor VCYT or FTRE?

In the previous week, Veracyte had 14 more articles in the media than Fortrea. MarketBeat recorded 17 mentions for Veracyte and 3 mentions for Fortrea. Fortrea's average media sentiment score of 0.93 beat Veracyte's score of 0.36 indicating that Fortrea is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veracyte 3 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Fortrea 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Fortrea (FTRE) Competitors

$15.44 +0.08 (+0.52%)

As of 01:21 PM Eastern

Compare

FTRE vs. SHC, CAI, RDNT, BLLN, and VCYT

Should you buy Fortrea stock or one of its competitors? MarketBeat compares Fortrea with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Fortrea include Sotera Health (SHC), Caris Life Sciences (CAI), RadNet (RDNT), Billiontoone (BLLN), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.

How does Fortrea compare to Sotera Health?

Fortrea (NASDAQ:FTRE) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, profitability, risk, analyst recommendations, media sentiment, institutional ownership, dividends and earnings.

Sotera Health has lower revenue, but higher earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fortrea	$2.72B	0.54	-$986.20M	-$4.91	N/A
Sotera Health	$1.16B	3.74	$77.94M	$0.41	37.24

In the previous week, Fortrea had 1 more articles in the media than Sotera Health. MarketBeat recorded 3 mentions for Fortrea and 2 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.15 beat Fortrea's score of 0.93 indicating that Sotera Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fortrea	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sotera Health	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Fortrea has a beta of 2.12, suggesting that its share price is 112% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.79, suggesting that its share price is 79% more volatile than the broader market.

Sotera Health has a net margin of 9.91% compared to Fortrea's net margin of -16.50%. Sotera Health's return on equity of 39.73% beat Fortrea's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fortrea	-16.50%	9.51%	1.96%
Sotera Health	9.91%	39.73%	7.05%

91.0% of Sotera Health shares are held by institutional investors. 0.7% of Fortrea shares are held by company insiders. Comparatively, 15.4% of Sotera Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Fortrea presently has a consensus price target of $17.25, suggesting a potential upside of 11.72%. Sotera Health has a consensus price target of $20.33, suggesting a potential upside of 33.16%. Given Sotera Health's stronger consensus rating and higher probable upside, analysts clearly believe Sotera Health is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70

Summary

Sotera Health beats Fortrea on 13 of the 16 factors compared between the two stocks.

How does Fortrea compare to Caris Life Sciences?

Fortrea (NASDAQ:FTRE) and Caris Life Sciences (NASDAQ:CAI) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.

In the previous week, Caris Life Sciences had 1 more articles in the media than Fortrea. MarketBeat recorded 4 mentions for Caris Life Sciences and 3 mentions for Fortrea. Fortrea's average media sentiment score of 0.93 beat Caris Life Sciences' score of 0.33 indicating that Fortrea is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fortrea	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Caris Life Sciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Fortrea presently has a consensus target price of $17.25, indicating a potential upside of 11.72%. Caris Life Sciences has a consensus target price of $27.56, indicating a potential upside of 75.29%. Given Caris Life Sciences' stronger consensus rating and higher probable upside, analysts plainly believe Caris Life Sciences is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45

Caris Life Sciences has lower revenue, but higher earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Caris Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fortrea	$2.72B	0.54	-$986.20M	-$4.91	N/A
Caris Life Sciences	$812.03M	5.47	-$68.09M	-$7.61	N/A

Caris Life Sciences has a net margin of 3.75% compared to Fortrea's net margin of -16.50%. Caris Life Sciences' return on equity of 98.28% beat Fortrea's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fortrea	-16.50%	9.51%	1.96%
Caris Life Sciences	3.75%	98.28%	48.87%

Summary

Caris Life Sciences beats Fortrea on 10 of the 13 factors compared between the two stocks.

How does Fortrea compare to RadNet?

RadNet (NASDAQ:RDNT) and Fortrea (NASDAQ:FTRE) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, institutional ownership, valuation, risk, analyst recommendations and earnings.

RadNet has a beta of 1.41, indicating that its stock price is 41% more volatile than the broader market. Comparatively, Fortrea has a beta of 2.12, indicating that its stock price is 112% more volatile than the broader market.

77.9% of RadNet shares are held by institutional investors. 5.6% of RadNet shares are held by company insiders. Comparatively, 0.7% of Fortrea shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

RadNet has higher earnings, but lower revenue than Fortrea. RadNet is trading at a lower price-to-earnings ratio than Fortrea, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.14B	1.94	-$18.65M	-$0.18	N/A
Fortrea	$2.72B	0.54	-$986.20M	-$4.91	N/A

RadNet presently has a consensus price target of $87.43, indicating a potential upside of 65.15%. Fortrea has a consensus price target of $17.25, indicating a potential upside of 11.72%. Given RadNet's stronger consensus rating and higher possible upside, research analysts plainly believe RadNet is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36

In the previous week, RadNet had 2 more articles in the media than Fortrea. MarketBeat recorded 5 mentions for RadNet and 3 mentions for Fortrea. Fortrea's average media sentiment score of 0.93 beat RadNet's score of 0.30 indicating that Fortrea is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fortrea	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

RadNet has a net margin of -0.66% compared to Fortrea's net margin of -16.50%. Fortrea's return on equity of 9.51% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
Fortrea	-16.50%	9.51%	1.96%

Summary

RadNet beats Fortrea on 11 of the 17 factors compared between the two stocks.

How does Fortrea compare to Billiontoone?

Fortrea (NASDAQ:FTRE) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment.

Billiontoone has a net margin of 0.00% compared to Fortrea's net margin of -16.50%. Fortrea's return on equity of 9.51% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fortrea	-16.50%	9.51%	1.96%
Billiontoone	N/A	N/A	N/A

Billiontoone has lower revenue, but higher earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fortrea	$2.72B	0.54	-$986.20M	-$4.91	N/A
Billiontoone	$305.11M	14.87	$7.45M	$0.55	179.40

Fortrea currently has a consensus target price of $17.25, suggesting a potential upside of 11.72%. Billiontoone has a consensus target price of $125.29, suggesting a potential upside of 26.97%. Given Billiontoone's stronger consensus rating and higher possible upside, analysts plainly believe Billiontoone is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Billiontoone had 2 more articles in the media than Fortrea. MarketBeat recorded 5 mentions for Billiontoone and 3 mentions for Fortrea. Billiontoone's average media sentiment score of 1.09 beat Fortrea's score of 0.93 indicating that Billiontoone is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fortrea	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Billiontoone	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Billiontoone beats Fortrea on 10 of the 13 factors compared between the two stocks.

How does Fortrea compare to Veracyte?

Veracyte (NASDAQ:VCYT) and Fortrea (NASDAQ:FTRE) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk and earnings.

Veracyte has higher earnings, but lower revenue than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veracyte	$517.15M	7.47	$66.35M	$1.09	44.44
Fortrea	$2.72B	0.54	-$986.20M	-$4.91	N/A

In the previous week, Veracyte had 14 more articles in the media than Fortrea. MarketBeat recorded 17 mentions for Veracyte and 3 mentions for Fortrea. Fortrea's average media sentiment score of 0.93 beat Veracyte's score of 0.36 indicating that Fortrea is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Veracyte	3 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Fortrea	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Veracyte has a beta of 1.98, meaning that its share price is 98% more volatile than the broader market. Comparatively, Fortrea has a beta of 2.12, meaning that its share price is 112% more volatile than the broader market.

Veracyte has a net margin of 16.25% compared to Fortrea's net margin of -16.50%. Fortrea's return on equity of 9.51% beat Veracyte's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veracyte	16.25%	9.07%	8.38%
Fortrea	-16.50%	9.51%	1.96%

Veracyte currently has a consensus price target of $47.57, indicating a potential downside of 1.79%. Fortrea has a consensus price target of $17.25, indicating a potential upside of 11.72%. Given Fortrea's higher probable upside, analysts plainly believe Fortrea is more favorable than Veracyte.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veracyte	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.56
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36

Summary

Veracyte beats Fortrea on 9 of the 15 factors compared between the two stocks.

Get Fortrea News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FTRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FTRE vs. The Competition

Export

Metric	Fortrea	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.46B	$3.26B	$6.26B	$12.40B
Dividend Yield	N/A	2.33%	2.69%	5.29%
P/E Ratio	-3.14	17.82	22.37	24.16
Price / Sales	0.54	321.51	547.57	124.65
Price / Cash	1.59	116.27	42.31	57.88
Price / Book	2.53	6.55	9.79	6.69
Net Income	-$986.20M	$24.20M	$3.56B	$336.98M
7 Day Performance	15.05%	-3.19%	-1.27%	0.45%
1 Month Performance	26.77%	0.39%	3.58%	4.95%
1 Year Performance	233.48%	46.56%	27.13%	34.01%

Fortrea Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FTRE Fortrea	3.8979 of 5 stars	$15.44 +0.5%	$17.25 +11.7%	+271.9%	$1.46B	$2.72B	N/A	14,300
SHC Sotera Health	3.7812 of 5 stars	$15.66 flat	$20.33 +29.8%	+23.2%	$4.47B	$1.16B	38.20	3,000
CAI Caris Life Sciences	4.7627 of 5 stars	$15.55 flat	$27.56 +77.2%	N/A	$4.40B	$812.03M	N/A	1,846	Analyst Downgrade
RDNT RadNet	3.7995 of 5 stars	$54.40 flat	$87.43 +60.7%	-6.8%	$4.28B	$2.04B	N/A	11,264
BLLN Billiontoone	4.809 of 5 stars	$85.92 flat	$125.29 +45.8%	N/A	$3.95B	$305.11M	156.22	620	Positive News Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:FTRE) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Fortrea (FTRE) Competitors

FTRE vs. SHC, CAI, RDNT, BLLN, and VCYT

How does Fortrea compare to Sotera Health?

Summary

How does Fortrea compare to Caris Life Sciences?

Summary

How does Fortrea compare to RadNet?

Summary

How does Fortrea compare to Billiontoone?

Summary

How does Fortrea compare to Veracyte?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FTRE vs. The Competition

Fortrea Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Fortrea (FTRE) Competitors

FTRE vs. SHC, CAI, RDNT, BLLN, and VCYT

How does Fortrea compare to Sotera Health?

Which has better valuation & earnings, FTRE or SHC?

Does the media prefer FTRE or SHC?

Which has more volatility and risk, FTRE or SHC?

Is FTRE or SHC more profitable?

Do institutionals & insiders hold more shares of FTRE or SHC?

Do analysts rate FTRE or SHC?

Summary

How does Fortrea compare to Caris Life Sciences?

Does the media prefer FTRE or CAI?

Do analysts recommend FTRE or CAI?

Which has stronger valuation & earnings, FTRE or CAI?

Is FTRE or CAI more profitable?

Summary

How does Fortrea compare to RadNet?

Which has more risk & volatility, RDNT or FTRE?

Do institutionals and insiders believe in RDNT or FTRE?

Which has preferable earnings and valuation, RDNT or FTRE?

Do analysts recommend RDNT or FTRE?

Does the media refer more to RDNT or FTRE?

Is RDNT or FTRE more profitable?

Summary

How does Fortrea compare to Billiontoone?

Is FTRE or BLLN more profitable?

Which has higher earnings & valuation, FTRE or BLLN?

Do analysts rate FTRE or BLLN?

Does the media refer more to FTRE or BLLN?

Summary

How does Fortrea compare to Veracyte?

Which has stronger valuation and earnings, VCYT or FTRE?

Does the media favor VCYT or FTRE?

Which has more risk & volatility, VCYT or FTRE?

Is VCYT or FTRE more profitable?

Do analysts recommend VCYT or FTRE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FTRE vs. The Competition

Fortrea Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools